US 7670806
ADP-ribosyl acceptor hydrolase 3 (ARH3) polypeptides and methods of use
granted A61PA61P43/00
Quick answer
US patent 7670806 (ADP-ribosyl acceptor hydrolase 3 (ARH3) polypeptides and methods of use) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P43/00